Harmony Biosciences Holdings, Inc. SEC filings HRMY
Harmony Biosciences Holdings, Inc. has 460 filings in SEC EDGAR's recent list, going back to Feb 14, 2020. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 15, 2025 | — |
| CORRESP | Letter to the SEC | Apr 9, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| SC TO-T/A | Filing | Oct 11, 2023 | — |
| SC TO-T/A | Filing | Oct 5, 2023 | — |
| SC TO-T/A | Filing | Sep 27, 2023 | — |
| SC TO-T/A | Filing | Sep 14, 2023 | — |
| CORRESP | Letter to the SEC | Sep 14, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2023 | — |
| CORRESP | Letter to the SEC | Sep 12, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2023 | — |
| SC TO-T | Filing | Aug 28, 2023 | — |
| SC TO-C | Filing | Aug 14, 2023 | — |
| SC TO-C | Filing | Aug 14, 2023 | — |
| EFFECT | Filing | Aug 18, 2020 | — |
| CERT | Filing | Aug 18, 2020 | — |
| CORRESP | Letter to the SEC | Aug 14, 2020 | — |
| CORRESP | Letter to the SEC | Aug 14, 2020 | — |
| 8-A12B | Filing | Aug 14, 2020 | — |
| CORRESP | Letter to the SEC | Jul 31, 2020 | — |
| DRS/A | Filing | Jun 12, 2020 | — |
| DRSLTR | Filing | Jun 11, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2020 | — |
| DRS | Filing | Feb 14, 2020 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HRMY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802665
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.